/de
The EPO introduced the latest version of the Guidelines for Examination on 1 March 2023. Some of the revisions are highlighted below.
A recent decision from the EPO’s Boards of Appeal (T 0702/20) provides a practical example of where the boundary lies in terms of
After years of uncertainty in the timeline of the Unified Patent Court (UPC), it has just been announced that Germany will ratify
The European Patent Office (EPO) has recently ruled that patients in a clinical trial were not members of the public such that
The way of determining the compliance period of a UK divisional application is changing on 1 May 2023. From 1 May 2023
The EPO has recently issued a decision confirming that oral proceedings before examining divisions, the Legal Division, the Receiving Section and now,
The Unified Patent Court (UPC) have today announced that the start of the Sunrise Period for the new UPC is being delayed
As of 1 September 2022, the EPO are providing a new, free of charge, service that involves carrying out a top-up search
Plausibility: Insights from the G 2/21 preliminary opinion The EPO’s Enlarged Board of Appeal (EBA) referral G 2/21 will hopefully clarify the
The Chartered Institute of Patent Attorneys (CIPA) has reported that the Administrative Council of the EPO passed a package of rules, on